| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
3
3
5
3
5
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Holdings
The fund invests in companies its management team believes are undervalued.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 1.96 | 1.96 |
| Stocks | 98.04 | 98.04 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 0.0 | 0.0 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Medtronic, Inc. | MDT | 14.36 | 3.44 |
| United Technologies Corp | UTX | 11.68 | 3.43 |
| Hartford Financial Services Group Inc | HIG | 24.15 | 3.14 |
| Pfizer Inc | PFE | 16.19 | 3.12 |
| Occidental Petroleum Corporation | OXY | 15.12 | 3.06 |
| Citigroup Inc | C | 15.98 | 3.0 |
| American International Group Inc | AIG | 16.69 | 2.94 |
| JPMorgan Chase & Co | JPM | 10.55 | 2.9 |
| Procter & Gamble Co | PG | 15.12 | 2.68 |
| Kimberly-Clark Corporation | KMB | 23.3 | 2.58 |
